首页> 外文OA文献 >A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

【2h】

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

机译：人单克隆抗Ang2抗体导致浅抗肿瘤活性与VEGF抑制剂和临床前模型的化疗剂组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jeffrey L. Brown; Z. Alexander Cao; Maria Pinzon-Ortiz; Jane Kendrew; Corinne Reimer; Shenghua Wen; Joe Q. Zhou; Mohammad Tabrizi; Steve Emery; Brenda McDermott; Lourdes Pablo; Patricia McCoon; Vahe Bedian; David C. Blakey;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. [J] . Brown JL, Cao ZA, Pinzon Ortiz M, Molecular cancer therapeutics . 2010,第1期

机译：人单克隆抗ANG2抗体在临床前模型中与VEGF抑制剂和化学治疗剂联合使用可产生广泛的抗肿瘤活性。
2. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [J] . Youzhi Xu, Wenjie Lu, Peng Yang, BMC Cancer . 2015,第1期

机译：小分子药物YL529除其已知的抗肿瘤活性外，还抑制VEGF-D诱导的临床前肿瘤模型中的淋巴管生成和转移。
3. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [J] . Youzhi Xu, Wenjie Lu, Peng Yang, BMC Cancer . 2015,第1期

机译：小分子药物YL529除其已知的抗肿瘤活性外，还抑制VEGF-D诱导的临床前肿瘤模型中的淋巴管生成和转移。
4. Anti-Tumor Activity of DLX1008, a Single-Chain Antibody Fragment Binding to VEGF-A, in an In Vivo Preclinical Model of Kaposi Sarcoma [C] . Titus Kretzschmar, Sang-Hoon Sin, Douglas Phillips, PEGS . 2015

机译：DLX1008的抗肿瘤活性，单链抗体片段与VEGF-A结合，在Kaposi Sarcoma的体内临床前模型中
5. Structural basis of antigen recognition by anti-HIV-1 broadly neutralizing human monoclonal antibodies against the third variable region of gp120. [D] . Burke, Valicia Julia. 2009

机译：抗HIV-1抗原识别的结构基础可广泛中和针对gp120第三可变区的人单克隆抗体。
6. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [O] . Youzhi Xu, Wenjie Lu, Peng Yang, 2015

机译：除已知的抗肿瘤活性外小分子药物YL529还抑制临床前肿瘤模型中VEGF-D诱导的淋巴管生成和转移
7. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [O] . Youzhi Xu, Wenjie Lu, Peng Yang, 2015

机译：除已知的抗肿瘤活性外，小分子药物YL529还抑制VEGF-D诱导的临床前肿瘤模型中的淋巴管生成和转移

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

著录项

引文网络

相似文献

相关主题

期刊订阅